DealdocEquity Purchase Agreement • April 26th, 2022Contract TypeEquity Purchase AgreementFiledApril 26th, 2022$26 million: Grifols acquiring 35% of Aradigm’s common stock on a fully diluted basis at a price per share of $0.124 on shareholders approval
$26 million: Grifols acquiring 35% of Aradigm’s common stock on a fully diluted basis at a price per share of $0.124 on shareholders approval